Swipe om te navigeren naar een ander artikel
Analysis of the first results of off-site percutaneous coronary interventions (PCI) and fractional flow reserve (FFR) measurements at VieCuri Medical Centre for Northern Limburg in Venlo.
Off-site PCI is accepted in the European and American Cardiac Guidelines as the need for PCI increases and it has been proven to be a safe treatment option for acute coronary syndrome.
Retrospective cohort study reporting characteristics, PCI and FFR specifications, complications and 6-month follow-up for all consecutive patients from the beginning of off-site PCI in Venlo until July 2012. If possible, the data were compared with those of Medical Centre Alkmaar, the first off-site PCI centre in the Netherlands.
Of the 333 patients, 19 (5.7 %) had a procedural complication. At 6 months, a major adverse cardiovascular event (MACE) occurred in 43 (13.1 %) patients. There were no deaths or emergency surgery related to the PCI or FFR procedures. There was no significant difference in occurrence of a MACE or adverse cerebral event between the Alkmaar and Venlo population in the 30-day follow-up.
This study demonstrates off-site PCI at VieCuri Venlo to have a high success rate. Furthermore, there was a low complication rate, low MACE and no procedure-related mortality.
Miller LH, Toklu B, Rauch J, et al. Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization. J Invasive Cardiol. 2012;24(7):309–15. PubMed PMID: 22781467. PubMed
McGrath PD, Malenka DJ, Wennberg DE, et al. Changing outcomes in percutaneous coronary interventions: a study of 34,752 procedures in northern New England, 1990 to 1997. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 1999;34(3):674–80. PubMed PMID: 10483947. PubMedCrossRef
Tamburino C, Russo G, Nicosia A, et al. Prophylactic abciximab in elective coronary stenting: results of a randomized trial. J Invasive Cardiol. 2002;14(2):72–9. PubMed PMID: 11818641. PubMed
Smith SC, Dove JT, Jacobs AK, et al. American College of Cardiology/American Heart Association Task Force on Practice Guideline and the Society for Cardiac Angiography and Interventions (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty); ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines) - executive summary. Circulation. 2001;103(24):3019–41. PubMedCrossRef
Dehmer GJ, Blankenship J, Wharton Jr TP, et al. The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2007;69:471–8. PubMedCrossRef
Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. J Am Med Assoc. 2002;287:1943–51. CrossRef
Peels JOJ, Hautvast RWM, de Swart, et al. Percutaneous coronary intervention without on site surgical back-up; two-years registry of a large Dutch community hospital. Int J Cardiol. 2007;132:59–65. CrossRef
Singh PP, Singh M, Bedi US, et al. Outcomes of nonemergent percutaneous coronary intervention with an without on-site surgical backup: a meta-analysis. Am J Ther. 2011;18:22–8. CrossRef
Wharton TP. Nonemergent percutaneous coronary intervention with off-site surgery backup; an emerging new path tot access. Crit Path Cardiol. 2005;4(2):98–106. CrossRef
Levine G, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:44–112. CrossRef
Nederlandse Vereniging voor Cardiologie: Dutch guidelines for interventional cardiology; Institutional and operator competance and requirements for training. 2004.
Dawkins KD, Gershlick T, de Belder M, et al. Joint Working Group on Percutaneous Coronary Intervention of the British Cardiovascular Intervention Society and the British Cardiac Society; Percutaneous coronary intervention: recommendations for good practice and training. Heart. 2005;91:1–27. CrossRef
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012 Dec 17. PubMed PMID: 23247304.
Piek JJ, Aengevaeren WR, Appelman Y, et al. Praktijkgids Optimale Zorg bij Acute Coronair Syndroom: VMSzorg. 2010.
Mol KA, Meeder JG, Duygun A, et al. Treating ST-elevation myocardial infarction within 90 minutes in the Netherlands: goal not yet achieved. 2013. [Submitted].
Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78(2):486–502. PubMedCrossRef
Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76(1):142–54. PubMed PMID: 3109764. PubMedCrossRef
- The first year of the Venlo percutaneous coronary intervention program: procedural and 6-month clinical outcomes
K. A. Mol
B. M. Rahel
R. P. Th. Troquay
J. G. Meeder
- Bohn Stafleu van Loghum